Rockland boosts life sciences portfolio with purchase of antibody line

21st Century Biochemicals agreed to sell its line of Epi-Plus antibodies, which are used in epigenetic studies, to Rockland Immunochemicals. The price was not disclosed. The deal will bolster Rockland's life science tools portfolio. The Epi-Plus brand is co-owned by Novus Biologicals.

View Full Article in:

Genetic Engineering & Biotechnology News · GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ